UK cost agency speeds approval of Bristol melanoma drug cocktail
June 16, 2016 at 19:01 PM EDT
LONDON, June 17 (Reuters) - British melanoma patients will be the first in Europe to receive a new drug cocktail combining two immunotherapy treatments, following an unusually rapid approval by the country's healthcare cost agency NICE on Friday.
